Grahaem Brown, Patrick Round, Andrew Bodnar, Edward Scolnick, George Daley, Bennett Shapiro | GenomeWeb

Grahaem Brown has been appointed director of development at Celltech. Brown previously worked in drug development for 20 years at Pfizer, Pharmacia, Novartis, and GlaxoSmithKline. Prior to that, he worked in hospital medicine for 10 years, including two years in Malaysia. He is qualified in medicine at University College Hospital in London, and has been accredited in internal and tropical medicine.

Patrick Round, previous director of development at Celltech, has become global director for CDP 870.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.